Bioxyne Ltd has released a press release.
Investor Presentation November 2024
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Bioxyne
- Bioxyne Extends Contract with Aura Therapeutics
- Response to ASX Aware Query
- Reinstatement to Quotation
- Announcement 21.8.2024 Clarifying Statement
- Suspension from Official Quotation
Later from Bioxyne
- Response to ASX Price Query
- Addendum to Presentation dated 18 November 2024
- Revenue Guidance
- Quarterly Activities Report December 2024 Revised
- BXN H1 FY25 Results Presentation
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne